ID   ANK3_RAT                Reviewed;        2622 AA.
AC   O70511; Q574D7; Q574D8; Q574D9; Q574E0; Q574E2; Q8VDA0;
DT   09-JUL-2014, integrated into UniProtKB/Swiss-Prot.
DT   09-JUL-2014, sequence version 3.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=Ankyrin-3;
DE            Short=ANK-3;
DE   AltName: Full=Ankyrin-G;
GN   Name=Ank3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=9744885; DOI=10.1083/jcb.142.6.1571;
RA   Zhang X., Bennett V.;
RT   "Restriction of 480/270-kD ankyrin G to axon proximal segments requires
RT   multiple ankyrin G-specific domains.";
RL   J. Cell Biol. 142:1571-1581(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY (ISOFORMS 2; 3; 4; 5; 6 AND 7).
RC   STRAIN=Sprague-Dawley; TISSUE=Skeletal muscle;
RX   PubMed=11796721; DOI=10.1074/jbc.m111299200;
RA   Gagelin C., Constantin B., Deprette C., Ludosky M.A., Recouvreur M.,
RA   Cartaud J., Cognard C., Raymond G., Kordeli E.;
RT   "Identification of Ank(G107), a muscle-specific ankyrin-G isoform.";
RL   J. Biol. Chem. 277:12978-12987(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 5; 6 AND 7), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Skeletal muscle;
RX   PubMed=15953600; DOI=10.1016/j.yexcr.2005.04.013;
RA   Hopitzan A.A., Baines A.J., Ludosky M.A., Recouvreur M., Kordeli E.;
RT   "Ankyrin-G in skeletal muscle: tissue-specific alternative splicing
RT   contributes to the complexity of the sarcolemmal cytoskeleton.";
RL   Exp. Cell Res. 309:86-98(2005).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15579534; DOI=10.1073/pnas.0403711101;
RA   Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S.,
RA   Priori S.G., Bennett V.;
RT   "Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-
RT   G and expression of Nav1.5 on the surface of cardiomyocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:17533-17538(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH PKP2 AND GJA1, AND TISSUE SPECIFICITY.
RX   PubMed=21617128; DOI=10.1161/circresaha.111.247023;
RA   Sato P.Y., Coombs W., Lin X., Nekrasova O., Green K.J., Isom L.L.,
RA   Taffet S.M., Delmar M.;
RT   "Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the
RT   cardiac intercalated disc.";
RL   Circ. Res. 109:193-201(2011).
RN   [6]
RP   INTERACTION WITH PLEC AND FLNC, INTERACTION WITH PLEC AND FLNC (ISOFORM 7),
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21223964; DOI=10.1016/j.yexcr.2011.01.002;
RA   Maiweilidan Y., Klauza I., Kordeli E.;
RT   "Novel interactions of ankyrins-G at the costameres: the muscle-specific
RT   Obscurin/Titin-Binding-related Domain (OTBD) binds plectin and filamin C.";
RL   Exp. Cell Res. 317:724-736(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631; SER-855; SER-869;
RP   SER-875; SER-921; SER-924; SER-965; SER-967; SER-1121; SER-1458; SER-1984;
RP   SER-2102; SER-2114; SER-2117; SER-2457 AND SER-2544, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-1679 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-851 (ISOFORMS 4 AND 5), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Membrane-cytoskeleton linker. May participate in the
CC       maintenance/targeting of ion channels and cell adhesion molecules at
CC       the nodes of Ranvier and axonal initial segments (By similarity). In
CC       skeletal muscle, required for costamere localization of DMD and
CC       betaDAG1 (By similarity). Regulates KCNA1 channel activity in function
CC       of dietary Mg(2+) levels, and thereby contributes to the regulation of
CC       renal Mg(2+) reabsorption (By similarity). Required for intracellular
CC       adhesion and junctional conductance in myocytes, potentially via
CC       stabilization of GJA1/CX43 protein abundance and promotion of PKP2,
CC       GJA1/CX43, and SCN5A/Nav1.5 localization to cell-cell junctions
CC       (PubMed:21617128). {ECO:0000250|UniProtKB:G5E8K5,
CC       ECO:0000250|UniProtKB:Q12955, ECO:0000269|PubMed:21617128}.
CC   -!- SUBUNIT: May be a constituent of a NFASC/NRCAM/ankyrin G complex.
CC       Interacts with RHBG. Directly interacts with DMD and betaDAG1; this
CC       interaction does not interfere with DMD-binding and is required for DMD
CC       and betaDAG1 retention at costameres. Interacts (via N-terminal ANK
CC       repeats) with SCHIP1 isoform 7 (via C-terminus); this interaction is
CC       required for the localization at axon initial segments (AISs) and nodes
CC       of Ranvier (NRs) (By similarity). Interacts with PLEC and FLNC
CC       (PubMed:21223964). Interacts (via ANK repeats) with IQCJ-SCHIP1;
CC       required for IQCJ-SCHIP1 localization at axon initial segments (AIS)
CC       and nodes of Ranvier (By similarity). Interacts with SCHIP1 (By
CC       similarity). Interacts with KCNA1; this inhibits channel activity (By
CC       similarity). Interacts with SCN5A (By similarity). Interacts with PKP2
CC       and GJA1/CX43 (PubMed:21617128). {ECO:0000250|UniProtKB:G5E8K5,
CC       ECO:0000250|UniProtKB:Q12955, ECO:0000269|PubMed:21223964,
CC       ECO:0000269|PubMed:21617128}.
CC   -!- SUBUNIT: [Isoform 7]: Interacts (via its C-terminal muscle-specific
CC       Obscurin/Titin-Binding-related domain sequence) with PLEC and FLNC.
CC       {ECO:0000269|PubMed:21223964}.
CC   -!- INTERACTION:
CC       O70511-7; Q14315: FLNC; Xeno; NbExp=2; IntAct=EBI-9663485, EBI-489954;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q12955}. Cell projection, axon
CC       {ECO:0000269|PubMed:9744885}. Cell membrane
CC       {ECO:0000269|PubMed:21223964}. Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:15953600, ECO:0000269|PubMed:21223964}.
CC       Postsynaptic cell membrane {ECO:0000269|PubMed:11796721}. Lysosome
CC       {ECO:0000250|UniProtKB:G5E8K5}. Cell membrane, sarcolemma, T-tubule
CC       {ECO:0000269|PubMed:15579534}. Note=When transfected in root dorsal
CC       ganglia, predominantly located in the axolemma of the axon proximal
CC       segments (PubMed:9744885). Also associated with the plasma membrane in
CC       neuron cell bodies, although at a lower level than in the axon proximal
CC       segment (PubMed:9744885). Isoform 1 is restricted to the axolemma of
CC       the axon proximal segment. Isoforms containing the muscle-specific 76
CC       amino-acid insertion localize to the sarcolemma and on the postsynaptic
CC       membrane of neuromuscular junctions (PubMed:11796721).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=AnkG270;
CC         IsoId=O70511-1; Sequence=Displayed;
CC       Name=2; Synonyms=AnkG217;
CC         IsoId=O70511-2; Sequence=VSP_055005, VSP_055006, VSP_055007,
CC                                  VSP_055008, VSP_055009, VSP_055011;
CC       Name=3; Synonyms=AnkG197;
CC         IsoId=O70511-3; Sequence=VSP_055005, VSP_055006, VSP_055007,
CC                                  VSP_055008, VSP_055010, VSP_055012;
CC       Name=4; Synonyms=Ank130;
CC         IsoId=O70511-4; Sequence=VSP_055004, VSP_055008, VSP_055009,
CC                                  VSP_055013;
CC       Name=5; Synonyms=AnkG128;
CC         IsoId=O70511-5; Sequence=VSP_055004, VSP_055008, VSP_055009,
CC                                  VSP_055011;
CC       Name=6; Synonyms=AnkG109;
CC         IsoId=O70511-6; Sequence=VSP_055004, VSP_055008, VSP_055010,
CC                                  VSP_055013;
CC       Name=7; Synonyms=AnkG107;
CC         IsoId=O70511-7; Sequence=VSP_055004, VSP_055008, VSP_055010,
CC                                  VSP_055011;
CC   -!- TISSUE SPECIFICITY: Expressed in the heart (at protein level)
CC       (PubMed:21617128). Expressed in skeletal muscle (at protein level)
CC       (PubMed:21223964). Expressed at highest levels in brain and testis,
CC       followed by skin, kidney, liver and spleen (PubMed:15953600).
CC       {ECO:0000269|PubMed:15953600, ECO:0000269|PubMed:21223964,
CC       ECO:0000269|PubMed:21617128}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: May be specifically expressed in
CC       muscle tissues, including heart and skeletal muscle (extensor digitorum
CC       longus) (at protein level). {ECO:0000269|PubMed:11796721}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: May be specifically expressed in
CC       muscle tissues, including heart and skeletal muscle (extensor digitorum
CC       longus) (at protein level). {ECO:0000269|PubMed:11796721}.
CC   -!- TISSUE SPECIFICITY: [Isoform 4]: May be specifically expressed in
CC       muscle tissues, including heart and skeletal muscle (extensor digitorum
CC       longus) (at protein level). {ECO:0000269|PubMed:11796721}.
CC   -!- TISSUE SPECIFICITY: [Isoform 5]: May be specifically expressed in
CC       muscle tissues, including heart and skeletal muscle (extensor digitorum
CC       longus) (at protein level). {ECO:0000269|PubMed:11796721}.
CC   -!- TISSUE SPECIFICITY: [Isoform 6]: May be specifically expressed in
CC       muscle tissues, including heart and skeletal muscle (extensor digitorum
CC       longus) (at protein level). {ECO:0000269|PubMed:11796721}.
CC   -!- TISSUE SPECIFICITY: [Isoform 7]: Expressed in skeletal muscle, brain,
CC       lung, heart, testes and kidney. {ECO:0000269|PubMed:11796721}.
CC   -!- MISCELLANEOUS: [Isoform 2]: The 76 amino-acid long sequence from Asp-
CC       1888 to Val-1963 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: The 76 amino-acid long sequence from Asp-
CC       1710 to Val-1785 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: The 76 amino-acid long sequence from Asp-
CC       1077 to Val-1152 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: The 76 amino-acid long sequence from Asp-
CC       1060 to Val-1135 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 6]: The 76 amino-acid long sequence from Asp-
CC       881 to Val-956 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 7]: The 76 amino-acid long sequence from Asp-
CC       864 to Val-939 is encoded by a muscle-specific exon. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF102552; AAC78143.1; -; mRNA.
DR   EMBL; AJ428573; CAD21705.1; -; mRNA.
DR   EMBL; AJ812019; CAH19219.1; -; mRNA.
DR   EMBL; AJ812021; CAH19221.1; -; mRNA.
DR   EMBL; AJ812022; CAH19222.1; -; mRNA.
DR   EMBL; AJ812023; CAH19223.1; -; mRNA.
DR   EMBL; AJ812024; CAH19224.1; -; mRNA.
DR   RefSeq; NP_001029156.1; NM_001033984.1. [O70511-1]
DR   RefSeq; NP_113993.1; NM_031805.1. [O70511-2]
DR   PDB; 5YIP; X-ray; 1.85 A; B=1985-2010.
DR   PDB; 5YIQ; X-ray; 2.60 A; D=1985-2010.
DR   PDB; 6A9X; X-ray; 2.20 A; A=1987-2010.
DR   PDB; 6M3P; X-ray; 3.31 A; C/E=975-1465.
DR   PDB; 6M3R; X-ray; 4.31 A; E=975-1465.
DR   PDB; 7XCE; X-ray; 2.50 A; A=275-500.
DR   PDBsum; 5YIP; -.
DR   PDBsum; 5YIQ; -.
DR   PDBsum; 6A9X; -.
DR   PDBsum; 6M3P; -.
DR   PDBsum; 6M3R; -.
DR   PDBsum; 7XCE; -.
DR   AlphaFoldDB; O70511; -.
DR   SMR; O70511; -.
DR   BioGRID; 262995; 9.
DR   CORUM; O70511; -.
DR   DIP; DIP-60342N; -.
DR   IntAct; O70511; 9.
DR   MINT; O70511; -.
DR   STRING; 10116.ENSRNOP00000071472; -.
DR   GlyGen; O70511; 8 sites, 1 O-linked glycan (8 sites).
DR   iPTMnet; O70511; -.
DR   PhosphoSitePlus; O70511; -.
DR   SwissPalm; O70511; -.
DR   jPOST; O70511; -.
DR   PaxDb; 10116-ENSRNOP00000043687; -.
DR   ABCD; O70511; 6 sequenced antibodies.
DR   Ensembl; ENSRNOT00000085985.2; ENSRNOP00000072993.2; ENSRNOG00000053288.2. [O70511-3]
DR   Ensembl; ENSRNOT00000090273.2; ENSRNOP00000071942.2; ENSRNOG00000053288.2. [O70511-2]
DR   GeneID; 361833; -.
DR   KEGG; rno:361833; -.
DR   UCSC; RGD:620157; rat.
DR   AGR; RGD:620157; -.
DR   CTD; 288; -.
DR   RGD; 620157; Ank3.
DR   eggNOG; KOG4177; Eukaryota.
DR   GeneTree; ENSGT00940000154939; -.
DR   InParanoid; O70511; -.
DR   OrthoDB; 5474900at2759; -.
DR   PRO; PR:O70511; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0043194; C:axon initial segment; IDA:BHF-UCL.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0043034; C:costamere; IDA:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0014704; C:intercalated disc; IDA:BHF-UCL.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:RGD.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0033268; C:node of Ranvier; IDA:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0033270; C:paranode region of axon; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:BHF-UCL.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:RGD.
DR   GO; GO:0014731; C:spectrin-associated cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0045296; F:cadherin binding; IPI:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IPI:BHF-UCL.
DR   GO; GO:0140031; F:phosphorylation-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:BHF-UCL.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IBA:GO_Central.
DR   GO; GO:0030507; F:spectrin binding; IDA:BHF-UCL.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:BHF-UCL.
DR   GO; GO:0008089; P:anterograde axonal transport; IMP:RGD.
DR   GO; GO:0061564; P:axon development; IMP:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0071286; P:cellular response to magnesium ion; ISS:UniProtKB.
DR   GO; GO:0045162; P:clustering of voltage-gated sodium channels; IMP:RGD.
DR   GO; GO:0045184; P:establishment of protein localization; ISO:RGD.
DR   GO; GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; IMP:RGD.
DR   GO; GO:0043001; P:Golgi to plasma membrane protein transport; ISO:RGD.
DR   GO; GO:0010960; P:magnesium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0032507; P:maintenance of protein location in cell; IMP:RGD.
DR   GO; GO:0072660; P:maintenance of protein location in plasma membrane; ISO:RGD.
DR   GO; GO:0071709; P:membrane assembly; IGI:BHF-UCL.
DR   GO; GO:0000281; P:mitotic cytokinesis; ISO:RGD.
DR   GO; GO:1902260; P:negative regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0045806; P:negative regulation of endocytosis; IMP:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; IEP:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0007009; P:plasma membrane organization; ISO:RGD.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IMP:BHF-UCL.
DR   GO; GO:0010650; P:positive regulation of cell communication by electrical coupling; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0034112; P:positive regulation of homotypic cell-cell adhesion; IMP:RGD.
DR   GO; GO:1900827; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:BHF-UCL.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; IMP:RGD.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IMP:RGD.
DR   GO; GO:1903784; P:positive regulation of sodium ion import across plasma membrane; IMP:UniProtKB.
DR   GO; GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IMP:BHF-UCL.
DR   GO; GO:0099612; P:protein localization to axon; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL.
DR   GO; GO:0099159; P:regulation of modification of postsynaptic structure; IDA:SynGO.
DR   GO; GO:0043266; P:regulation of potassium ion transport; IDA:BHF-UCL.
DR   GO; GO:1903533; P:regulation of protein targeting; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   CDD; cd08803; Death_ank3; 1.
DR   Gene3D; 2.60.220.30; -; 2.
DR   Gene3D; 2.60.40.2660; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 3.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 1.
DR   InterPro; IPR037971; Ank3_Death.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR040745; Ankyrin_UPA.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR051165; Multifunctional_ANK_Repeat.
DR   InterPro; IPR000906; ZU5_dom.
DR   PANTHER; PTHR24123:SF49; ANKYRIN REPEAT AND DEATH DOMAIN-CONTAINING 1B; 1.
DR   PANTHER; PTHR24123; ANKYRIN REPEAT-CONTAINING; 1.
DR   Pfam; PF00023; Ank; 3.
DR   Pfam; PF12796; Ank_2; 7.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF17809; UPA_2; 1.
DR   Pfam; PF00791; ZU5; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 22.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00218; ZU5; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 3.
DR   SUPFAM; SSF47986; DEATH domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 21.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS51145; ZU5; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Cell membrane;
KW   Cell projection; Cytoplasm; Cytoskeleton; Lysosome; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Reference proteome; Repeat;
KW   Synapse.
FT   CHAIN           1..2622
FT                   /note="Ankyrin-3"
FT                   /id="PRO_0000429632"
FT   REPEAT          73..102
FT                   /note="ANK 1"
FT   REPEAT          106..135
FT                   /note="ANK 2"
FT   REPEAT          139..168
FT                   /note="ANK 3"
FT   REPEAT          172..201
FT                   /note="ANK 4"
FT   REPEAT          203..230
FT                   /note="ANK 5"
FT   REPEAT          242..271
FT                   /note="ANK 6"
FT   REPEAT          275..304
FT                   /note="ANK 7"
FT   REPEAT          308..337
FT                   /note="ANK 8"
FT   REPEAT          341..370
FT                   /note="ANK 9"
FT   REPEAT          374..403
FT                   /note="ANK 10"
FT   REPEAT          407..436
FT                   /note="ANK 11"
FT   REPEAT          440..469
FT                   /note="ANK 12"
FT   REPEAT          473..502
FT                   /note="ANK 13"
FT   REPEAT          506..535
FT                   /note="ANK 14"
FT   REPEAT          539..568
FT                   /note="ANK 15"
FT   REPEAT          572..601
FT                   /note="ANK 16"
FT   REPEAT          605..634
FT                   /note="ANK 17"
FT   REPEAT          638..667
FT                   /note="ANK 18"
FT   REPEAT          671..700
FT                   /note="ANK 19"
FT   REPEAT          704..733
FT                   /note="ANK 20"
FT   REPEAT          737..766
FT                   /note="ANK 21"
FT   REPEAT          770..799
FT                   /note="ANK 22"
FT   REPEAT          803..832
FT                   /note="ANK 23"
FT   DOMAIN          992..1147
FT                   /note="ZU5 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          1149..1296
FT                   /note="ZU5 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          2336..2420
FT                   /note="Death"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
FT   REGION          1..44
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          868..889
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1510..1539
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1968..1992
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2099..2147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2292..2312
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2568..2622
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..27
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2103..2120
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2121..2137
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2579..2622
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12955"
FT   MOD_RES         631
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         855
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         875
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         921
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         924
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         930
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8K5"
FT   MOD_RES         965
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         967
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8K5"
FT   MOD_RES         1621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8K5"
FT   MOD_RES         1624
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8K5"
FT   MOD_RES         1984
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2457
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12955"
FT   MOD_RES         2544
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1..880
FT                   /note="MAHAASQLKKNRDLEINAEEETEKKKKHRKRSRDRKKKSDANASYLRAARAG
FT                   HLEKALDYIKNGVDVNICNQNGLNALHLASKEGHVEVVSELLQREANVDAATKKGNTAL
FT                   HIASLAGQAEVVKVLVTNGANVNAQSQNGFTPLYMAAQENHLEVVRFLLDNGASQSLAT
FT                   EDGFTPLAVALQQGHDQVVSLLLENDTKGKVRLPALHIAARKDDTKAAALLLQNDTNAD
FT                   IESKMVVNRATESGFTPLHIAAHYGNINVATLLLNRAAAVDFTARNDITPLHVASKRGN
FT                   ANMVKLLLDRGAKIDAKTRDGLTPLHCGARSGHEQVVEMLLDRAAPILSKTKNGLSPLH
FT                   MATQGDHLNCVQLLLQHNVPVDDVTNDYLTALHVAAHCGHYKVAKVLLDKKANPNAKAL
FT                   NGFTPLHIACKKNRIRVMELLLKHGASIQAVTESGLTPIHVAAFMGHVNIVSQLMHHGA
FT                   SPNTTNVRGETALHMAARSGQAEVVRYLVQDGAQVEAKAKDDQTPLHISARLGKADIVQ
FT                   QLLQQGASPNAATTSGYTPLHLSAREGHEDVAAFLLDHGASLSITTKKGFTPLHVAAKY
FT                   GKLEVASLLLQKSASPDAAGKSGLTPLHVAAHYDNQKVALLLLDQGASPHAAAKNGYTP
FT                   LHIAAKKNQMDIATSLLEYGADANAVTRQGIASVHLAAQEGHVDMVSLLLSRNANVNLS
FT                   NKSGLTPLHLAAQEDRVNVAEVLVNQGAHVDAQTKMGYTPLHVGCHYGNIKIVNFLLQH
FT                   SAKVNAKTKNGYTPLHQAAQQGHTHIINVLLQNNASPNELTVNGNTALAIARRLGYISV
FT                   VDTLKVVTEEIMTTTTITEKHKMNVPETMNEVLDMSDDEVGKASAPEKLSDGEYISDGE
FT                   EG -> MALPHS (in isoform 4, isoform 5, isoform 6 and
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11796721,
FT                   ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055004"
FT   VAR_SEQ         1..36
FT                   /note="MAHAASQLKKNRDLEINAEEETEKKKKHRKRSRDRK -> MSEEAKEKTAKP
FT                   AHRKRKG (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055005"
FT   VAR_SEQ         234..241
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055006"
FT   VAR_SEQ         858..878
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055007"
FT   VAR_SEQ         922..927
FT                   /note="LRSFSS -> PKISS (in isoform 2, isoform 3, isoform 4,
FT                   isoform 5, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11796721,
FT                   ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055008"
FT   VAR_SEQ         1466..2444
FT                   /note="KRYSYLTEPSMKTVERSSGTARSLPTTYSHKPFFSTRPYQSWTTTPITVPGP
FT                   AKSGSLSSSPSNTPSASPLKSIWSVSTPSPIKSTLGASTTSSVKSISDVASPIRSFRTI
FT                   SSPIRTVASPSPYNTQVASGTLGRVPTITEATPIKGVAPNSTLSSRTSPVTTAGSLLEK
FT                   SSITMTPPASPKANITMYSSSLPFKSIITSAAPLISSPLKSVVSPTKSAADVISTAKAA
FT                   MASTLSSPLKQMSGHAEVALVNGSVSPLKYPSSSALINGCKATATLQDKISTATNAVSS
FT                   VVSAAPDTVEKALSTTTAMPFSPLRSYVSAAAPSAFQSLRAPSASALYNSLGPSVGVTT
FT                   SSVTSSIITVPVYSVGNVLAEPALKKLPDSNSLTKSAAALLSPIKTLTTETRPQPHFNR
FT                   TSSPVKSSLFLASSALKPSVPSSLSSSQEILKDVAEMKEDLMRMTAILQTDVPEEKPFQ
FT                   TDLPREGRIDDEEPFKIVEKVKEDLVKVSEILKKDVCVESKGPPKSPKSDKGHSPEDDW
FT                   TEFSSEEIREARQAAASHAPSLPERVHGKANLTRVIDYLTNDIGSSSLTNLKYKFEEAK
FT                   KEGEERQKRILKPAMALQEHKLKMPPASMRPSTSEKELCKMADSFFGTDAILESPDDFS
FT                   QHDQDKSPLSDSGFETRSEKTPSAPQSAESTGPKPLFHEVPIPPVITETRTEVVHVIRS
FT                   YEPSTGEIPQSQPEDPVSPKPPPTFMELEPKPTALSIKEKVKAFQMKASSEEEDHSRVL
FT                   SKGMRVKEETHITTTTRMVYHSPPGSECASERIEETMSVHDIMKAFQSGRDPSKELAGL
FT                   FEHKSAMSPDVAKSAAETSAQHAEKDNQMKPKLERIIEVHIEKGPQSPCERTDIRMAIV
FT                   ADHLGLSWTELARELNFSVDEINQIRVENPNSLISQSFMLLKKWVTRDGKNATTDALTS
FT                   VLTKINRIDIVTLLEGPIFDYGNISGTRSFADENNVFHDPVD -> PQSPCERTDIRMA
FT                   IVADHLGLSWTELARELNFSVDEINQIRVENPNSLISQSFMLLKKWVTRDGKNATTDAL
FT                   TSVLTKINRIDIVTLLEGPIFDYGNISGTRSFADENNVFHDPVDGHPSFQVELETPMGL
FT                   YCTPPTPFQQDDHFSDNSSIESPFRTPSRLSDGLMPSQGSIEHPAGGPPVVTAEDTSLE
FT                   DSKMDDSVTVTETADPLDVDESQLKDLCQSECAHCWASVPGVPSGGPQAEPLRAQTRKV
FT                   GVSSEQQEKGDSGPEEEMADDKVRSLFEDIQLEEVEAEEMTEDEGQAILNRVPRAELAM
FT                   SSLA (in isoform 2, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055009"
FT   VAR_SEQ         1466..2328
FT                   /note="Missing (in isoform 3, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11796721,
FT                   ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055010"
FT   VAR_SEQ         2601
FT                   /note="K -> KDLRHSESDSSSEEERRVTTRVIRRRVIIKGEEAKTIPGESVTEEQF
FT                   TDEEGNLITRKITRKVIRRIGPQERKQDDV (in isoform 2, isoform 5 and
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11796721,
FT                   ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055011"
FT   VAR_SEQ         2601
FT                   /note="K -> KQVKSPGEAFTRMTACCYKDLRHSESDSSSEEERRVTTRVIRRRVII
FT                   KGEEAKTIPGESVTEEQFTDEEGNLITRKITRKVIRRIGPQERKQDDV (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055012"
FT   VAR_SEQ         2601
FT                   /note="K -> KVKSPGEAFTRMTACCYKDLRHSESDSSSEEERRVTTRVIRRRVIIK
FT                   GEEAKTIPGESVTEEQFTDEEGNLITRKITRKVIRRIGPQERKQDDV (in isoform
FT                   4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15953600"
FT                   /id="VSP_055013"
FT   CONFLICT        246
FT                   /note="P -> S (in Ref. 1; AAC78143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        635
FT                   /note="A -> S (in Ref. 3; CAH19223/CAH19224)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        667
FT                   /note="A -> P (in Ref. 1; AAC78143)"
FT                   /evidence="ECO:0000305"
FT   HELIX           279..286
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           289..297
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           312..318
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           322..330
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           345..351
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           355..363
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           378..385
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           388..396
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           411..417
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           421..429
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           444..451
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           454..462
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           477..484
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   HELIX           487..495
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   STRAND          988..998
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1003..1010
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1014..1017
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1022..1024
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1026..1032
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1049..1059
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1063..1073
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   TURN            1079..1082
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1083..1094
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1096..1098
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1106..1110
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1122..1128
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1130..1137
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1140..1148
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1151..1153
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1165..1169
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1171..1173
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1185..1190
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1194..1199
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1210..1215
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1217..1229
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1250..1255
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1269..1271
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1277..1287
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1290..1295
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   TURN            1299..1301
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1302..1313
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1317..1326
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1336..1343
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   HELIX           1349..1353
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1357..1360
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1365..1368
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1371..1380
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1392..1394
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1401..1405
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1418..1424
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1437..1442
FT                   /evidence="ECO:0007829|PDB:6M3P"
FT   STRAND          1989..1991
FT                   /evidence="ECO:0007829|PDB:5YIQ"
FT   HELIX           1994..2003
FT                   /evidence="ECO:0007829|PDB:5YIP"
FT   MOD_RES         O70511-2:1679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         O70511-4:851
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         O70511-5:851
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   2622 AA;  284443 MW;  A17F304D792333F5 CRC64;
     MAHAASQLKK NRDLEINAEE ETEKKKKHRK RSRDRKKKSD ANASYLRAAR AGHLEKALDY
     IKNGVDVNIC NQNGLNALHL ASKEGHVEVV SELLQREANV DAATKKGNTA LHIASLAGQA
     EVVKVLVTNG ANVNAQSQNG FTPLYMAAQE NHLEVVRFLL DNGASQSLAT EDGFTPLAVA
     LQQGHDQVVS LLLENDTKGK VRLPALHIAA RKDDTKAAAL LLQNDTNADI ESKMVVNRAT
     ESGFTPLHIA AHYGNINVAT LLLNRAAAVD FTARNDITPL HVASKRGNAN MVKLLLDRGA
     KIDAKTRDGL TPLHCGARSG HEQVVEMLLD RAAPILSKTK NGLSPLHMAT QGDHLNCVQL
     LLQHNVPVDD VTNDYLTALH VAAHCGHYKV AKVLLDKKAN PNAKALNGFT PLHIACKKNR
     IRVMELLLKH GASIQAVTES GLTPIHVAAF MGHVNIVSQL MHHGASPNTT NVRGETALHM
     AARSGQAEVV RYLVQDGAQV EAKAKDDQTP LHISARLGKA DIVQQLLQQG ASPNAATTSG
     YTPLHLSARE GHEDVAAFLL DHGASLSITT KKGFTPLHVA AKYGKLEVAS LLLQKSASPD
     AAGKSGLTPL HVAAHYDNQK VALLLLDQGA SPHAAAKNGY TPLHIAAKKN QMDIATSLLE
     YGADANAVTR QGIASVHLAA QEGHVDMVSL LLSRNANVNL SNKSGLTPLH LAAQEDRVNV
     AEVLVNQGAH VDAQTKMGYT PLHVGCHYGN IKIVNFLLQH SAKVNAKTKN GYTPLHQAAQ
     QGHTHIINVL LQNNASPNEL TVNGNTALAI ARRLGYISVV DTLKVVTEEI MTTTTITEKH
     KMNVPETMNE VLDMSDDEVG KASAPEKLSD GEYISDGEEG EDAITGDTDK YLGPQDLKEL
     GDDSLPAEGY VGFSLGARSA SLRSFSSDRS YTLNRSSYAR DSMMIEELLV PSKEQHLPFT
     REFDSDSLRH YSWAADTLDN VNLVSSPVHS GFLVSFMVDA RGGSMRGSRH HGMRIIIPPR
     KCTAPTRITC RLVKRHKLAN PPPMVEGEGL ASRLVEMGPA GAQFLGPVIV EIPHFGSMRG
     KERELIVLRS ENGETWKEHQ FDSKNEDLSE LLNGMDEELD SPEELGTKRI CRIITKDFPQ
     YFAVVSRIKQ ESNQIGPEGG ILSSTTVPLV QASFPEGALT KRIRVGLQAQ PVPEETVKKI
     LGNKATFSPI VTVEPRRRKF HKPITMTIPV PPPSGEGVSN GYKGDTTPSL RLLCSITGGT
     SPAQWEDITG TTPLTFIKDC VSFTTNVSAR FWLADCHQVL ETVGLASQLY RELICVPYMA
     KFVVFAKTND PVESSLRCFC MTDDRVDKTL EQQENFEEVA RSKDIEVLEG KPIYVDCYGN
     LAPLTKGGQQ LVFNFYSFKE NRLPFSIKVR DTSQEPCGRL SFLKEPKTTK GLPQTAVCNL
     NITLPAHKKA EKADRRQSFT SLALRKRYSY LTEPSMKTVE RSSGTARSLP TTYSHKPFFS
     TRPYQSWTTT PITVPGPAKS GSLSSSPSNT PSASPLKSIW SVSTPSPIKS TLGASTTSSV
     KSISDVASPI RSFRTISSPI RTVASPSPYN TQVASGTLGR VPTITEATPI KGVAPNSTLS
     SRTSPVTTAG SLLEKSSITM TPPASPKANI TMYSSSLPFK SIITSAAPLI SSPLKSVVSP
     TKSAADVIST AKAAMASTLS SPLKQMSGHA EVALVNGSVS PLKYPSSSAL INGCKATATL
     QDKISTATNA VSSVVSAAPD TVEKALSTTT AMPFSPLRSY VSAAAPSAFQ SLRAPSASAL
     YNSLGPSVGV TTSSVTSSII TVPVYSVGNV LAEPALKKLP DSNSLTKSAA ALLSPIKTLT
     TETRPQPHFN RTSSPVKSSL FLASSALKPS VPSSLSSSQE ILKDVAEMKE DLMRMTAILQ
     TDVPEEKPFQ TDLPREGRID DEEPFKIVEK VKEDLVKVSE ILKKDVCVES KGPPKSPKSD
     KGHSPEDDWT EFSSEEIREA RQAAASHAPS LPERVHGKAN LTRVIDYLTN DIGSSSLTNL
     KYKFEEAKKE GEERQKRILK PAMALQEHKL KMPPASMRPS TSEKELCKMA DSFFGTDAIL
     ESPDDFSQHD QDKSPLSDSG FETRSEKTPS APQSAESTGP KPLFHEVPIP PVITETRTEV
     VHVIRSYEPS TGEIPQSQPE DPVSPKPPPT FMELEPKPTA LSIKEKVKAF QMKASSEEED
     HSRVLSKGMR VKEETHITTT TRMVYHSPPG SECASERIEE TMSVHDIMKA FQSGRDPSKE
     LAGLFEHKSA MSPDVAKSAA ETSAQHAEKD NQMKPKLERI IEVHIEKGPQ SPCERTDIRM
     AIVADHLGLS WTELARELNF SVDEINQIRV ENPNSLISQS FMLLKKWVTR DGKNATTDAL
     TSVLTKINRI DIVTLLEGPI FDYGNISGTR SFADENNVFH DPVDGWQNET PSGSLESPAQ
     ARRITGGLLD RLDDSSDQVR DPITSYLTGE AGKFEANGNH AEVIPEAKAK AYFPESQNDI
     GKQSIKENLK PKTHGCGRAE EPVSPLTAYQ KSLEETSKLV IEDAPKPCVP VGMKKMTRTP
     ADGKARLNLQ EEEGSARSEP KQGEGYKVKT KKEIRNVEKK AH
//
